Perioperative	O
Transfusion	B:C0005841
of	O
Leukocyte	O
-	O
depleted	O
Blood	O
Products	I:C0456388
in	O
Contemporary	O
Radical	O
Cystectomy	I:C0194401
Cohort	O
Does	O
Not	O
Adversely	O
Impact	O
Short	O
-	O
term	O
Survival	O
.	O

Perioperative	O
Transfusion	O
of	O
Leukocyte	B:C0023516
-	O
depleted	O
Blood	O
Products	I:C0456388
in	O
Contemporary	O
Radical	O
Cystectomy	I:C0194401
Cohort	O
Does	O
Not	O
Adversely	O
Impact	O
Short	O
-	O
term	O
Survival	O
.	O

Perioperative	O
Transfusion	O
of	O
Leukocyte	O
-	O
depleted	O
Blood	B:C0456388
Products	I:C0456388
in	O
Contemporary	O
Radical	O
Cystectomy	I:C0194401
Cohort	O
Does	O
Not	O
Adversely	O
Impact	O
Short	O
-	O
term	O
Survival	O
.	O

Perioperative	O
Transfusion	O
of	O
Leukocyte	O
-	O
depleted	O
Blood	O
Products	I:C0456388
in	O
Contemporary	O
Radical	B:C0194401
Cystectomy	I:C0194401
Cohort	O
Does	O
Not	O
Adversely	O
Impact	O
Short	O
-	O
term	O
Survival	O
.	O

Perioperative	O
Transfusion	O
of	O
Leukocyte	O
-	O
depleted	O
Blood	O
Products	I:C0456388
in	O
Contemporary	O
Radical	O
Cystectomy	I:C0194401
Cohort	B:C0599755
Does	O
Not	O
Adversely	O
Impact	O
Short	O
-	O
term	O
Survival	O
.	O

To	O
evaluate	B:C0220825
the	O
effect	O
of	O
leukoreduced	O
-	O
only	O
perioperative	O
blood	O
transfusion	I:C0005841
(	O
perioperative	O
blood	I:C0005841
transfusion	I:C0005841
)	O
and	O
corresponding	O
survival	O
outcomes	O
in	O
a	O
radical	O
cystectomy	I:C0194401
cohort	O
of	O
patients	O
.	O

To	O
evaluate	O
the	O
effect	O
of	O
leukoreduced	O
-	O
only	O
perioperative	O
blood	B:C0005841
transfusion	I:C0005841
(	O
perioperative	O
blood	I:C0005841
transfusion	I:C0005841
)	O
and	O
corresponding	O
survival	O
outcomes	O
in	O
a	O
radical	O
cystectomy	I:C0194401
cohort	O
of	O
patients	O
.	O

To	O
evaluate	O
the	O
effect	O
of	O
leukoreduced	O
-	O
only	O
perioperative	O
blood	O
transfusion	I:C0005841
(	O
perioperative	B:C0005841
blood	I:C0005841
transfusion	I:C0005841
)	O
and	O
corresponding	O
survival	O
outcomes	O
in	O
a	O
radical	O
cystectomy	I:C0194401
cohort	O
of	O
patients	O
.	O

To	O
evaluate	O
the	O
effect	O
of	O
leukoreduced	O
-	O
only	O
perioperative	O
blood	O
transfusion	I:C0005841
(	O
perioperative	O
blood	I:C0005841
transfusion	I:C0005841
)	O
and	O
corresponding	O
survival	O
outcomes	O
in	O
a	O
radical	B:C0194401
cystectomy	I:C0194401
cohort	O
of	O
patients	O
.	O

To	O
evaluate	O
the	O
effect	O
of	O
leukoreduced	O
-	O
only	O
perioperative	O
blood	O
transfusion	I:C0005841
(	O
perioperative	O
blood	I:C0005841
transfusion	I:C0005841
)	O
and	O
corresponding	O
survival	O
outcomes	O
in	O
a	O
radical	O
cystectomy	I:C0194401
cohort	B:C0599755
of	O
patients	O
.	O

We	O
analyzed	B:C0936012
data	O
from	O
1026	O
patients	O
who	O
underwent	O
radical	O
cystectomy	I:C0194401
at	O
our	O
institution	O
.	O

We	O
analyzed	O
data	O
from	O
1026	O
patients	O
who	O
underwent	O
radical	B:C0194401
cystectomy	I:C0194401
at	O
our	O
institution	O
.	O

We	O
analyzed	O
data	O
from	O
1026	O
patients	O
who	O
underwent	O
radical	O
cystectomy	I:C0194401
at	O
our	O
institution	B:C2607850
.	O

perioperative	B:C0005841
blood	I:C0005841
transfusion	I:C0005841
was	O
defined	O
as	O
transfusion	O
in	O
the	O
intraoperative	O
or	O
within	O
the	O
postoperative	O
hospitalization	O
period	O
.	O

perioperative	O
blood	I:C0005841
transfusion	I:C0005841
was	O
defined	O
as	O
transfusion	B:C0005841
in	O
the	O
intraoperative	O
or	O
within	O
the	O
postoperative	O
hospitalization	O
period	O
.	O

perioperative	O
blood	I:C0005841
transfusion	I:C0005841
was	O
defined	O
as	O
transfusion	O
in	O
the	O
intraoperative	O
or	O
within	O
the	O
postoperative	O
hospitalization	B:C0019993
period	O
.	O

Cox	B:C0010235
proportional	I:C0010235
hazards	I:C0010235
were	O
performed	O
to	O
measure	O
the	O
association	O
between	O
perioperative	O
blood	I:C0005841
transfusion	I:C0005841
,	O
patient	O
variables	O
,	O
and	O
3	O
primary	O
end	O
points	O
:	O
recurrence	O
-	I:C2919551
free	I:C2919551
survival	I:C2919551
,	O
disease	O
-	O
specific	O
survival	O
,	O
and	O
overall	O
survival	O
.	O

Cox	O
proportional	I:C0010235
hazards	I:C0010235
were	O
performed	O
to	O
measure	O
the	O
association	O
between	O
perioperative	B:C0005841
blood	I:C0005841
transfusion	I:C0005841
,	O
patient	O
variables	O
,	O
and	O
3	O
primary	O
end	O
points	O
:	O
recurrence	O
-	I:C2919551
free	I:C2919551
survival	I:C2919551
,	O
disease	O
-	O
specific	O
survival	O
,	O
and	O
overall	O
survival	O
.	O

Cox	O
proportional	I:C0010235
hazards	I:C0010235
were	O
performed	O
to	O
measure	O
the	O
association	O
between	O
perioperative	O
blood	I:C0005841
transfusion	I:C0005841
,	O
patient	O
variables	O
,	O
and	O
3	O
primary	O
end	O
points	O
:	O
recurrence	B:C2919551
-	I:C2919551
free	I:C2919551
survival	I:C2919551
,	O
disease	O
-	O
specific	O
survival	O
,	O
and	O
overall	O
survival	O
.	O

Kaplan	O
-	O
Meier	O
curves	O
estimated	O
survival	B:C2919552
times	I:C2919552
and	O
were	O
compared	O
with	O
log	O
-	I:C0022885
rank	I:C0022885
test	I:C0022885
.	O

Kaplan	O
-	O
Meier	O
curves	O
estimated	O
survival	O
times	I:C2919552
and	O
were	O
compared	O
with	O
log	B:C0022885
-	I:C0022885
rank	I:C0022885
test	I:C0022885
.	O

Overall	O
,	O
of	O
a	O
total	O
of	O
1026	O
patients	O
,	O
341	O
(	O
33.2	O
%	O
)	O
received	O
leukoreduced	O
perioperative	B:C0005841
blood	I:C0005841
transfusion	I:C0005841
.	O

The	O
median	B:C1522577
follow	I:C1522577
-	I:C1522577
up	I:C1522577
was	O
27.5	O
months	O
.	O

Transfused	O
patients	O
were	O
more	O
likely	O
to	O
be	O
female	B:C0043210
,	O
had	O
higher	O
estimated	O
blood	I:C1443559
loss	I:C1443559
,	O
lower	O
preoperative	O
hemoglobin	O
,	O
were	O
more	O
likely	O
to	O
have	O
received	O
neoadjuvant	O
chemotherapy	O
,	O
or	O
had	O
undergone	O
a	O
continent	O
urinary	I:C4289741
diversion	I:C4289741
.	O

Transfused	O
patients	O
were	O
more	O
likely	O
to	O
be	O
female	O
,	O
had	O
higher	O
estimated	B:C1443559
blood	I:C1443559
loss	I:C1443559
,	O
lower	O
preoperative	O
hemoglobin	O
,	O
were	O
more	O
likely	O
to	O
have	O
received	O
neoadjuvant	O
chemotherapy	O
,	O
or	O
had	O
undergone	O
a	O
continent	O
urinary	I:C4289741
diversion	I:C4289741
.	O

Transfused	O
patients	O
were	O
more	O
likely	O
to	O
be	O
female	O
,	O
had	O
higher	O
estimated	O
blood	I:C1443559
loss	I:C1443559
,	O
lower	O
preoperative	O
hemoglobin	B:C0019046
,	O
were	O
more	O
likely	O
to	O
have	O
received	O
neoadjuvant	O
chemotherapy	O
,	O
or	O
had	O
undergone	O
a	O
continent	O
urinary	I:C4289741
diversion	I:C4289741
.	O

Transfused	O
patients	O
were	O
more	O
likely	O
to	O
be	O
female	O
,	O
had	O
higher	O
estimated	O
blood	I:C1443559
loss	I:C1443559
,	O
lower	O
preoperative	O
hemoglobin	O
,	O
were	O
more	O
likely	O
to	O
have	O
received	O
neoadjuvant	B:C0600558
chemotherapy	O
,	O
or	O
had	O
undergone	O
a	O
continent	O
urinary	I:C4289741
diversion	I:C4289741
.	O

Transfused	O
patients	O
were	O
more	O
likely	O
to	O
be	O
female	O
,	O
had	O
higher	O
estimated	O
blood	I:C1443559
loss	I:C1443559
,	O
lower	O
preoperative	O
hemoglobin	O
,	O
were	O
more	O
likely	O
to	O
have	O
received	O
neoadjuvant	O
chemotherapy	B:C3665472
,	O
or	O
had	O
undergone	O
a	O
continent	O
urinary	I:C4289741
diversion	I:C4289741
.	O

Transfused	O
patients	O
were	O
more	O
likely	O
to	O
be	O
female	O
,	O
had	O
higher	O
estimated	O
blood	I:C1443559
loss	I:C1443559
,	O
lower	O
preoperative	O
hemoglobin	O
,	O
were	O
more	O
likely	O
to	O
have	O
received	O
neoadjuvant	O
chemotherapy	O
,	O
or	O
had	O
undergone	O
a	O
continent	B:C4289741
urinary	I:C4289741
diversion	I:C4289741
.	O

Higher	O
pathologic	B:C0027651
tumor	I:C0027651
and	O
nodal	O
stage	I:C0008902
were	O
observed	O
more	O
frequently	O
in	O
patients	O
who	O
received	O
perioperative	O
blood	I:C0005841
transfusion	I:C0005841
.	O

Higher	O
pathologic	O
tumor	I:C0027651
and	O
nodal	B:C0008902
stage	I:C0008902
were	O
observed	O
more	O
frequently	O
in	O
patients	O
who	O
received	O
perioperative	O
blood	I:C0005841
transfusion	I:C0005841
.	O

Higher	O
pathologic	O
tumor	I:C0027651
and	O
nodal	O
stage	I:C0008902
were	O
observed	O
more	O
frequently	O
in	O
patients	O
who	O
received	O
perioperative	B:C0005841
blood	I:C0005841
transfusion	I:C0005841
.	O

On	O
multivariable	O
analysis	O
,	O
perioperative	B:C0005841
blood	I:C0005841
transfusion	I:C0005841
was	O
not	O
associated	O
with	O
worse	O
recurrence	O
-	I:C2919551
free	I:C2919551
survival	I:C2919551
,	O
disease	O
-	O
specific	O
survival	O
,	O
and	O
overall	O
survival	O
(	O
all	O
P	O
>	O
.05	O
)	O
.	O

On	O
multivariable	O
analysis	O
,	O
perioperative	O
blood	I:C0005841
transfusion	I:C0005841
was	O
not	O
associated	O
with	O
worse	O
recurrence	B:C2919551
-	I:C2919551
free	I:C2919551
survival	I:C2919551
,	O
disease	O
-	O
specific	O
survival	O
,	O
and	O
overall	O
survival	O
(	O
all	O
P	O
>	O
.05	O
)	O
.	O

In	O
addition	O
,	O
no	O
differences	O
were	O
found	O
in	O
regard	O
to	O
timing	O
of	O
transfusion	B:C0005841
,	O
that	O
is	O
,	O
intraoperative	O
vs	O
postoperative	O
,	O
in	O
distinct	O
analysis	O
.	O

In	O
addition	O
,	O
no	O
differences	O
were	O
found	O
in	O
regard	O
to	O
timing	O
of	O
transfusion	O
,	O
that	O
is	O
,	O
intraoperative	O
vs	O
postoperative	O
,	O
in	O
distinct	O
analysis	B:C0936012
.	O

No	O
significant	O
association	O
was	O
found	O
between	O
leukoreduced	O
perioperative	B:C0005841
blood	I:C0005841
transfusion	I:C0005841
and	O
worse	O
survival	O
outcomes	O
at	O
short	O
-	O
term	O
follow	O
-	I:C1522577
up	I:C1522577
in	O
a	O
contemporary	O
cohort	O
of	O
cystectomy	O
patients	O
.	O

No	O
significant	O
association	O
was	O
found	O
between	O
leukoreduced	O
perioperative	O
blood	I:C0005841
transfusion	I:C0005841
and	O
worse	O
survival	O
outcomes	O
at	O
short	O
-	O
term	O
follow	B:C1522577
-	I:C1522577
up	I:C1522577
in	O
a	O
contemporary	O
cohort	O
of	O
cystectomy	O
patients	O
.	O

No	O
significant	O
association	O
was	O
found	O
between	O
leukoreduced	O
perioperative	O
blood	I:C0005841
transfusion	I:C0005841
and	O
worse	O
survival	O
outcomes	O
at	O
short	O
-	O
term	O
follow	O
-	I:C1522577
up	I:C1522577
in	O
a	O
contemporary	O
cohort	B:C0599755
of	O
cystectomy	O
patients	O
.	O

No	O
significant	O
association	O
was	O
found	O
between	O
leukoreduced	O
perioperative	O
blood	I:C0005841
transfusion	I:C0005841
and	O
worse	O
survival	O
outcomes	O
at	O
short	O
-	O
term	O
follow	O
-	I:C1522577
up	I:C1522577
in	O
a	O
contemporary	O
cohort	O
of	O
cystectomy	B:C0010651
patients	O
.	O

Prospective	O
long	B:C1517942
-	I:C1517942
term	I:C1517942
follow	I:C1517942
-	I:C1517942
up	I:C1517942
is	O
warranted	O
.	O

